Literature DB >> 6791675

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.

A P Wilson, F E Neal.   

Abstract

The in vitro chemosensitivity of primary monolayer cultures of human ovarian tumours to a wide range of chemotherapeutic agents has been determined using 3H-leucine incorporation as an index of cytotoxicity. Of 67 specimens received, 35 have been successfully cultured and tested for chemosensitivity. Drugs tested included alkylating agents, antibiotics, antimitotics, antimetabolites and progestogens. The overall incidence of efficacy of the drugs corresponded with the incidence which might be expected from data on the clinical response rates produced by the various drugs. Cultures from the tumour cells of treated patients generally showed greater resistance than tumours of untreated patients. Correlation between in vitro results and in vivo response was positive in all 8 patients receiving first-line chemotherapy and in 57% (4/7) patients receiving second-line chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791675      PMCID: PMC2010732          DOI: 10.1038/bjc.1981.170

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Pharmacokinetics of actinoymcin D in patients with malignant melanoma.

Authors:  M H Tattersall; J E Sodergren; S K Dengupta; D H Trites; E J Modest; E Frei
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

2.  Pharmacokinetics of vindesine and vincristine in humans.

Authors:  R J Owellen; M A Root; F O Hains
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

3.  Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma.

Authors:  G D Malkasian; D G Decker; E O Jorgensen; J H Edmonson
Journal:  Cancer Treat Rep       Date:  1977-08

4.  Pharmacokinetics and metabolism of vinblastine in humans.

Authors:  R J Owellen; C A Hartke; F O Hains
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

5.  Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease.

Authors:  T K Wheeler; P P Dendy; A Dawson
Journal:  Oncology       Date:  1974       Impact factor: 2.935

6.  Single agent vs combination chemotherapy in the treatment of ovarian cancer.

Authors:  J J Barlow; M S Piver
Journal:  Obstet Gynecol       Date:  1977-05       Impact factor: 7.661

7.  Use of high dose corticosteroids in patients with inoperable brain tumours.

Authors:  A Lieberman; Y LeBrun; P Glass; A Goodgold; W Lux; A Wise; J Ransohoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-07       Impact factor: 10.154

8.  Preliminary pharmacokinetic model for adriamycin (NSC-123127).

Authors:  P A Harris; J F Gross
Journal:  Cancer Chemother Rep       Date:  1975 Jul-Aug

9.  Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment.

Authors:  R I Freshney; J Paul; I M Kane
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

10.  Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy.

Authors:  R J Berry; A H Laing; J Wells
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640

View more
  13 in total

1.  Activity of 2-fluoro-Ara AMP against gynecologic tumors in the soft agar assay.

Authors:  J A Ajani; B Tomasovic; G Spitzer; J J Kavanagh; D Thielvoldt; F L Baker; D Gershenson
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

2.  Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma.

Authors:  B Hagen; F Walseth; R A Walstad; T Iversen; O G Nilsen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 3.  The human tumor colony-forming chemosensitivity assay: a biological and clinical review.

Authors:  E C Bradley; B F Issell; R Hellman
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

4.  Pharmacokinetics of thio-TEPA at two different doses.

Authors:  B Hagen; R A Walstad; O G Nilsen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  Antitumor activity of treosulfan against human breast carcinomas.

Authors:  P Köpf-Maier; G Sass
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro.

Authors:  M D Shelley; R G Fish; M Adams; I Kerby
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

7.  The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy.

Authors:  B Ward; S Mather; J Shepherd; M Crowther; L Hawkins; K Britton; M L Slevin
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

8.  A comparison of three assays used for the in vitro chemosensitivity testing of human tumours.

Authors:  A P Wilson; C H Ford; C E Newman; A Howell
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640

9.  Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay.

Authors:  A P Simmonds; E C McDonald
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

10.  DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.

Authors:  E Erba; M Vaghi; S Pepe; G Amato; M Bistolfi; P Ubezio; C Mangioni; F Landoni; L Morasca
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.